---
figid: PMC7957768__ijms-22-02466-g003
figlink: pmc/articles/PMC7957768/figure/ijms-22-02466-f003/
number: Figure 3
caption: 'Triterpenoids target metabolic pathways in prostate cancer. Triterpenoids
  activate the cellular energy sensor AMPK, promoting catabolic pathways and ATP synthesis,
  but inhibit the anabolic pathways required for cell growth and proliferation. OA
  inhibits the enzyme fatty acid synthase (FASN), which catalyzes long-chain fatty
  acid synthesis. OA also induces expression of PKM1 and reduces expression of PKM2,
  interfering with the biosynthetic pathways that are sustained by the expression
  of PKM2 in cancer cells. PCa cells utilize glutamine, which is transformed to glutamate
  and then to α-ketoglutarate. The latter is shuttled into the TCA cycle. Ursolic
  acid (UA) inhibits the glutamine transporter ASCT2 and glutamine uptake, and thus
  the energetic pathways mediated by glutamine. OA: Oleanolic Acid, UA: Ursolic acid,
  NA: Nummularic acid, PA: Plectranthoic acid, G6P: Glucose-6-phosphate, F6P: Fructose-6-phosphate,
  F1,6P: Fructose 1,6-bisphosphate, PFK: phosphofructokinase, G3P: Glyceraldehyde-3-phosphate,
  3-PG: 3-phosphoglycerate, PEP: phosphoenolpyruvate, PPP: pentose phosphate pathway.'
pmcid: PMC7957768
papertitle: Targeting Mitochondrial Metabolism in Prostate Cancer with Triterpenoids.
reftext: Kenza Mamouni, et al. Int J Mol Sci. 2021 Mar;22(5):2466.
pmc_ranked_result_index: '815'
pathway_score: 0.97091
filename: ijms-22-02466-g003.jpg
figtitle: Triterpenoids target metabolic pathways in prostate cancer
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7957768__ijms-22-02466-g003.html
  '@type': Dataset
  description: 'Triterpenoids target metabolic pathways in prostate cancer. Triterpenoids
    activate the cellular energy sensor AMPK, promoting catabolic pathways and ATP
    synthesis, but inhibit the anabolic pathways required for cell growth and proliferation.
    OA inhibits the enzyme fatty acid synthase (FASN), which catalyzes long-chain
    fatty acid synthesis. OA also induces expression of PKM1 and reduces expression
    of PKM2, interfering with the biosynthetic pathways that are sustained by the
    expression of PKM2 in cancer cells. PCa cells utilize glutamine, which is transformed
    to glutamate and then to α-ketoglutarate. The latter is shuttled into the TCA
    cycle. Ursolic acid (UA) inhibits the glutamine transporter ASCT2 and glutamine
    uptake, and thus the energetic pathways mediated by glutamine. OA: Oleanolic Acid,
    UA: Ursolic acid, NA: Nummularic acid, PA: Plectranthoic acid, G6P: Glucose-6-phosphate,
    F6P: Fructose-6-phosphate, F1,6P: Fructose 1,6-bisphosphate, PFK: phosphofructokinase,
    G3P: Glyceraldehyde-3-phosphate, 3-PG: 3-phosphoglycerate, PEP: phosphoenolpyruvate,
    PPP: pentose phosphate pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAG2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG3
  - FASN
  - PAEP
  - MPC2
  - Glucose
  - Nucleotide
  - Fatty acids
  - Citrate
  - PFK
  - Glycerol
  - Glutamine
  - TCA
  - Pyruvate
  - Glutamate
genes:
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: FASN,
  symbol: FASN
  source: hgnc_symbol
  hgnc_symbol: FASN
  entrez: '2194'
- word: (АMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: (АMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: (АMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: (АMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: (АMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: (АMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: (АMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: РЕР
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: MPC2
  symbol: MPC2
  source: hgnc_symbol
  hgnc_symbol: MPC2
  entrez: '25874'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: Nucleotide
  source: MESH
  identifier: D009711
- word: Fatty acids
  source: MESH
  identifier: D005227
- word: Citrate
  source: MESH
  identifier: C102006
- word: PFK
  source: MESH
  identifier: C043951
- word: Glycerol
  source: MESH
  identifier: D005990
- word: Glutamine
  source: MESH
  identifier: C578860
- word: TCA
  source: MESH
  identifier: C000589078
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Glutamate
  source: ''
  identifier: ''
diseases: []
---
